B. Riley Securities resumed coverage on Trinity Capital with a new price target
$TRIN
Finance: Consumer Services
Finance
B. Riley Securities resumed coverage of Trinity Capital with a rating of Buy and set a new price target of $14.50
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/2/2024 | $13.00 | Equal Weight → Underweight | Wells Fargo |
| 8/22/2023 | $15.50 | Neutral → Buy | Compass Point |
| 8/7/2023 | $15.00 | Underperform → Mkt Perform | Keefe Bruyette |
| 7/5/2023 | $15.00 | Buy | Jefferies |
| 3/13/2023 | $13.50 → $11.00 | Mkt Perform → Underperform | Keefe Bruyette |
| 11/7/2022 | $30.00 | Positive → Neutral | Susquehanna |
| 11/4/2022 | $16.00 → $12.50 | Outperform → Mkt Perform | Keefe Bruyette |
| 10/27/2022 | $18.00 → $12.75 | Buy → Neutral | Compass Point |
21st Consecutive Quarter of a Consistent or Increased Dividend PHOENIX, March 19, 2025 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) (the "Company"), a leading international alternative asset manager, today announced that its Board of Directors declared a cash dividend of $0.51 per share with respect to the quarter ending March 31, 2025. This is an equivalent dividend compared to the fourth quarter of 2024 and marks the 21st consecutive quarter of a consistent or increased dividend for Trinity shareholders. Summary of First Quarter 2025 Dividend: Declaration Date March 1
Return on Average Equity hits 17.4% in Q4 Record Quarterly Net Investment Income of $35 million, or $0.58 per share Record Annual Net Investment Income of $116 million, or $2.20 per share 2024 Total Investment Income grows 31% year-over-year PHOENIX, Feb. 26, 2025 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) (the "Company"), a leading alternative asset manager, today announced its financial results for the fourth quarter and year ended December 31, 2024. Fourth Quarter 2024 Highlights Total investment income of $70.8 million, an increase of 48.1% year-over-yearNet inves
PHOENIX, Feb. 4, 2025 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) ("Trinity Capital" or the "Company"), a leading alternative asset manager, today announced preliminary estimates of financial results for the fourth quarter and year ended December 31, 2024. Trinity Capital's preliminary estimate of its fourth quarter 2024 net investment income is in the range of $0.58 to $0.60 per share. Trinity Capital's preliminary estimate of its net asset value per share as of December 31, 2024 is in the range of $13.32 to $13.37. Trinity Capital's preliminary estimate of its investm
21st Consecutive Quarter of a Consistent or Increased Dividend PHOENIX, March 19, 2025 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) (the "Company"), a leading international alternative asset manager, today announced that its Board of Directors declared a cash dividend of $0.51 per share with respect to the quarter ending March 31, 2025. This is an equivalent dividend compared to the fourth quarter of 2024 and marks the 21st consecutive quarter of a consistent or increased dividend for Trinity shareholders. Summary of First Quarter 2025 Dividend: Declaration Date March 1
PHOENIX, March 12, 2025 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) (the "Company"), a leading international alternative asset manager, today announced the appointment of Zach Taffet as Director of Capital Formation & Investor Relations. Mr. Taffet will help drive the strategic direction for the Company's private fund strategies and management of institutional capital through its RIA platform. Mr. Taffet brings nearly a decade of experience in capital raising and investor relations, most recently as a member of BlackRock's Infrastructure Capital Formation Team for their
PHOENIX, March 3, 2025 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) (the "Company"), a leading alternative asset manager, today announced the appointment of John Orlando as Managing Director of Life Sciences, based in Boston. Mr. Orlando, an established leader with over a decade of experience in venture lending, has built a strong reputation as a trusted partner within the Life Sciences industry. "We are thrilled to welcome John to our team," said Rob Lake, Senior Managing Director, Life Sciences at Trinity Capital. "We believe his industry experience and deep relationsh
Wells Fargo downgraded Trinity Capital from Equal Weight to Underweight and set a new price target of $13.00
Compass Point upgraded Trinity Capital from Neutral to Buy and set a new price target of $15.50
Keefe Bruyette upgraded Trinity Capital from Underperform to Mkt Perform and set a new price target of $15.00
4 - Trinity Capital Inc. (0001786108) (Issuer)
4 - Trinity Capital Inc. (0001786108) (Issuer)
4 - Trinity Capital Inc. (0001786108) (Issuer)
8-K - Trinity Capital Inc. (0001786108) (Filer)
SCHEDULE 13G/A - Trinity Capital Inc. (0001786108) (Subject)
10-K - Trinity Capital Inc. (0001786108) (Filer)
4 - Trinity Capital Inc. (0001786108) (Issuer)
4 - Trinity Capital Inc. (0001786108) (Issuer)
4 - Trinity Capital Inc. (0001786108) (Issuer)
PHOENIX, March 12, 2025 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) (the "Company"), a leading international alternative asset manager, today announced the appointment of Zach Taffet as Director of Capital Formation & Investor Relations. Mr. Taffet will help drive the strategic direction for the Company's private fund strategies and management of institutional capital through its RIA platform. Mr. Taffet brings nearly a decade of experience in capital raising and investor relations, most recently as a member of BlackRock's Infrastructure Capital Formation Team for their
PHOENIX, March 3, 2025 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) (the "Company"), a leading alternative asset manager, today announced the appointment of John Orlando as Managing Director of Life Sciences, based in Boston. Mr. Orlando, an established leader with over a decade of experience in venture lending, has built a strong reputation as a trusted partner within the Life Sciences industry. "We are thrilled to welcome John to our team," said Rob Lake, Senior Managing Director, Life Sciences at Trinity Capital. "We believe his industry experience and deep relationsh
PHOENIX, July 22, 2024 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:TRIN) ("Trinity" or the "Company"), a leading provider of diversified financial solutions to growth-oriented companies, today announced the appointment of Josh Ruben as Managing Director of Life Sciences. Mr. Ruben, an established leader with over a decade of experience in investment banking, has a long track record of supporting life science companies with over $50 billion of transactions completed across M&A and capital raises. He is based in Phoenix, AZ. "We are delighted to welcome Josh to our team," said